Skip to content

The Use of a Novel Peer Education Program for Improving PTSD Treatment Engagement Among Veterans

Randomized Controlled Trial of AboutFace: A Novel Video Storytelling Resource to Improve Access, Engagement, and Utilization of Mental Health Treatment Among Veterans With PTSD

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03521999
Acronym
AboutFace
Enrollment
330
Registered
2018-05-11
Start date
2018-08-01
Completion date
2022-09-30
Last updated
2024-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Posttraumatic Stress Disorder, PTSD

Keywords

PTSD, peer resource, Veterans, web-based intervention, digital story telling

Brief summary

Behavioral health problems among Veterans have raised awareness of the critical need for more reliable, effective, and accessible ways to recognize those in need, direct them to help, and ensure that they receive the best evidence-based care available. AboutFace is a novel peer education program that features the personal stories of Veterans and is designed to improve Veterans' likelihood of engaging in Post Traumatic Stress Disorder (PTSD) specialty care. Using a randomized controlled study design the investigators propose to compare the efficacy of AboutFace relative to standard care for improving treatment engagement and outcomes. Additional data from VA providers will provide valuable information on wide scale implementation and dissemination of AboutFace. If AboutFace increases access of services, data will have broad implications for overcoming barriers to care for Veterans with PTSD and other stigmatized conditions.

Detailed description

Anticipated Impacts on Veterans Health Care: Behavioral health problems among Veterans have raised awareness of the critical need for more reliable, effective, and accessible means to recognize those in need, direct them to help, and ensure that they receive the best treatment available. Research has suggested that people are most responsive to advice and education when it comes from someone to whom they can relate. AboutFace is a peer education resource for Veterans that was developed, launched, and recently updated by the National Center for PTSD (NCPTSD) based on Health Services Research &Development (HSR&D) funded pilot data. AboutFace features personal stories of Veterans and is designed to improve mental health treatment engagement among Veterans with PTSD and related comorbidities. The study team, which includes the NCPTSD, recently completed a usability assessment and pilot feasibility trial of AboutFace under HSR&D grant #14-360-1. Data from this study (1) guided improvements to AboutFace for increasing PTSD treatment initiation and engagement; and (2) demonstrated the feasibility of the methodology for the proposed study. If AboutFace is found to increase Veterans' initiation and engagement in PTSD treatment, study data will have broad implications for overcoming barriers to care for Veterans with PTSD and other stigmatized conditions. Background: At least 1 in 10 Veterans meet criteria for PTSD related to their military experience. Treatment for PTSD is widely available, and national dissemination initiatives have increased Veterans' access to best-practice interventions. However, treatment-seeking remains strikingly low; most Veterans with PTSD do not seek mental health services due to perceived stigma and other barriers. NCPTSD developed and launched AboutFace, a public awareness campaign to help Veterans recognize PTSD and motivate them to seek evidence-based care. Since its development, AboutFace has earned three major awards and has had tens of thousands of visits. Despite the tremendous potential for AboutFace to reduce stigma, improve attitudes toward mental health treatment seeking, and to increase PTSD treatment initiation and engagement, it has yet to be formally evaluated or effectively implemented within Veterans Health Administration (VHA) practice settings. In addition to providing needed data on the efficacy of AboutFace and identifying strategies for effective implementation within VHA, this study will provide a greater understanding of the role and value of digital storytelling interventions to improve access to care for a wide range of stigmatized conditions. Objectives: The primary objectives of the study are to examine the impact of AboutFace on a) increasing PTSD treatment initiation and engagement; and b) decreasing stigma and negative attitudes toward mental health services. It is anticipated that Veterans in the AboutFace condition will be more likely to access and complete treatment than those receiving enhanced Usual Care (eUC) for PTSD. Finally, qualitative interviews with key stakeholders across the nation will be conducted to inform best practices for future implementation of AboutFace. Methods: A total of 376 Veterans referred for a PTSD assessment and recommended for treatment in the Charleston PTSD clinic will be enrolled in the study. Veterans will be randomized to receive AboutFace versus eUC. All Veterans will receive standard PTSD educational materials, and half will also be randomly assigned to receive AboutFace. Comparisons will be made across indices of treatment engagement \[i.e., initiated treatment (yes/no), total number of sessions completed;\]; changes in stigma and attitudes toward seeking mental health treatment; and changes in PTSD symptoms and quality of life. Veterans will be assessed on these indices at baseline, 1-month, 3-month, and 6-months.

Interventions

BEHAVIORALAboutFace

AboutFace is an online peer-to-peer digital storytelling resource for Veterans with PTSD. Veterans will have access to AboutFace while they are enrolled in PTSD specialty care through the Charleston PCT.

OTHEREnhanced Usual Care (eUC)

Enhanced Usual Care (eUC) includes access to a PTSD educational brochure. Veterans will have access to the brochure information while they are enrolled in PTSD specialty care through the Charleston PCT.

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Outcomes Assessor)

Masking description

Post-treatment assessors and a co-investigator in charge of randomization will be blind to condition assignment

Intervention model description

376 Veterans who are referred for a PTSD evaluation through the Charleston VAMC PTSD Clinic Team (PCT) and Telehealth Programs and are recommended for PTSD specialty care will be randomized to receive an online peer-to-peer digital storytelling resource \[AboutFace\] or an educational brochure for PTSD \[enhanced Usual Care; eUC\]

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Veterans must be referred for a PTSD evaluation through the Charleston VAMC PTSD Clinic Team (PCT) and Telehealth Programs and recommended for PTSD specialty care through the clinic.

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
PTSD Treatment Engagement (Yes/no)Baseline up to 60 daysDichotomous yes/no variable for whether or not a participant started at least one session of PTSD specialty care within 60 days of baseline. This measure indicates the number of participants who attended a minimum of one session of a PTSD treatment within 60 days of the initial baseline administration.
Total Number of PTSD Treatment SessionsBaseline up to 60 daysTotal number of PTSD treatment sessions completed from baseline to 60 days

Secondary

MeasureTime frameDescription
Posttraumatic Stress Disorder Checklist-5 (PCL-5)6 monthsThe PCL is a 20-item self-report measure of PTSD severity. The self-report rating scale is 0-4 for each symptom: Not at all, A little bit, Moderately, Quite a bit, and Extremely. Total score can range from 0-80.
Endorsed and Anticipated Stigma Inventory (EASI)6 monthsEASI assesses different dimensions of stigma-related beliefs about mental health among military personnel and Veterans. It measures 5 dimensions: beliefs about mental illness, beliefs about mental health treatment, beliefs about seeking treatment, concerns about stigma from loved ones, and concerns about stigma in the workplace. Scores range from 40- 200. Higher scores are indicative of greater stigma; thus improvement is evident in reduction of scores/reduction of stigma in mental health.
Patient Health Questionnaire (PHQ-8)6 monthsThe PHQ-8 is a brief questionnaire that scores each of the 8 Diagnostic Statistical Manual (DSM)-IV criteria for depression as 0 (not at all) to 3 (nearly every day) with higher total scores indicating greater symptoms. Scores range from 0-24. PHQ-8 scores of 5, 10, 15, and 20 represent mild, moderate, moderately severe, and severe depression respectively.
Quality of Life Index (QLI)6 monthsThe QLI is a 2-part, 33-item self-report measure of life satisfaction and importance regarding various aspects of life with higher scores representing better outcomes. Scores range from 0-30. An increase in score would represent an increase in life satisfaction.

Countries

United States

Participant flow

Recruitment details

Veterans will be referred following a PTSD evaluation through the Charleston VAMC PTSD Clinic Team (PCT) and Telehealth Programs and recommended for PTSD specialty care through the clinic

Participants by arm

ArmCount
AboutFace
Veterans in the AboutFACe arm will receive access to an online peer-to-peer digital storytelling resource for Veterans with PTSD AboutFace: AboutFace is an online peer-to-peer digital storytelling resource for Veterans with PTSD. Veterans will have access to AboutFace while they are enrolled in PTSD specialty care through the Charleston PCT.
165
Enhanced Usual Care (eUC)
Veterans in the Enhanced Usual Care (eUC) arm will receive an education brochure for PTSD Enhanced Usual Care (eUC): Enhanced Usual Care (eUC) includes access to a PTSD educational brochure. Veterans will have access to the brochure information while they are enrolled in PTSD specialty care through the Charleston PCT.
165
Total330

Withdrawals & dropouts

PeriodReasonFG000FG001
Completed 1 Month UpLost to Follow-up5958
Completed 3 Month Follow upDeath01
Completed 3 Month Follow upLost to Follow-up6459
Completed 6 Month FollowLost to Follow-up6670

Baseline characteristics

CharacteristicAboutFaceEnhanced Usual Care (eUC)Total
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
8 Participants4 Participants12 Participants
Age, Categorical
Between 18 and 65 years
157 Participants161 Participants318 Participants
Age, Continuous44.39 years
STANDARD_DEVIATION 11.57
43.17 years
STANDARD_DEVIATION 11.78
43.78 years
STANDARD_DEVIATION 11.68
Combat Veteran status
Desert Storm
17 Participants10 Participants27 Participants
Combat Veteran status
No Combat
48 Participants52 Participants100 Participants
Combat Veteran status
OEF/OIF
92 Participants93 Participants185 Participants
Combat Veteran status
Other
2 Participants4 Participants6 Participants
Combat Veteran status
Vietnam
5 Participants2 Participants7 Participants
Combat Veteran status
WWII/Korea
1 Participants1 Participants2 Participants
Employment Status
Full Time
79 Participants85 Participants164 Participants
Employment Status
Part Time
25 Participants17 Participants42 Participants
Employment Status
Retired
22 Participants18 Participants40 Participants
Employment Status
Student
15 Participants15 Participants30 Participants
Employment Status
Unemployed
24 Participants28 Participants52 Participants
Marital Status
Divorced
29 Participants29 Participants58 Participants
Marital Status
Married
106 Participants104 Participants210 Participants
Marital Status
Never Married
16 Participants22 Participants38 Participants
Marital Status
Other
6 Participants5 Participants11 Participants
Marital Status
Separated
6 Participants3 Participants9 Participants
Marital Status
Widowed
2 Participants1 Participants3 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants1 Participants2 Participants
Race (NIH/OMB)
Asian
2 Participants3 Participants5 Participants
Race (NIH/OMB)
Black or African American
76 Participants86 Participants162 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
8 Participants7 Participants15 Participants
Race (NIH/OMB)
White
78 Participants68 Participants146 Participants
Region of Enrollment
United States
165 Participants165 Participants330 Participants
Sex: Female, Male
Female
57 Participants46 Participants103 Participants
Sex: Female, Male
Male
108 Participants118 Participants226 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 1651 / 165
other
Total, other adverse events
3 / 1653 / 165
serious
Total, serious adverse events
0 / 1650 / 165

Outcome results

Primary

PTSD Treatment Engagement (Yes/no)

Dichotomous yes/no variable for whether or not a participant started at least one session of PTSD specialty care within 60 days of baseline. This measure indicates the number of participants who attended a minimum of one session of a PTSD treatment within 60 days of the initial baseline administration.

Time frame: Baseline up to 60 days

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
AboutFacePTSD Treatment Engagement (Yes/no)137 Participants
Enhanced Usual Care (eUC)PTSD Treatment Engagement (Yes/no)132 Participants
Primary

Total Number of PTSD Treatment Sessions

Total number of PTSD treatment sessions completed from baseline to 60 days

Time frame: Baseline up to 60 days

ArmMeasureValue (MEAN)Dispersion
AboutFaceTotal Number of PTSD Treatment Sessions8.5 Number of sessionsStandard Deviation 4.8
Enhanced Usual Care (eUC)Total Number of PTSD Treatment Sessions8.5 Number of sessionsStandard Deviation 4.4
Secondary

Endorsed and Anticipated Stigma Inventory (EASI)

EASI assesses different dimensions of stigma-related beliefs about mental health among military personnel and Veterans. It measures 5 dimensions: beliefs about mental illness, beliefs about mental health treatment, beliefs about seeking treatment, concerns about stigma from loved ones, and concerns about stigma in the workplace. Scores range from 40- 200. Higher scores are indicative of greater stigma; thus improvement is evident in reduction of scores/reduction of stigma in mental health.

Time frame: 6 months

Population: The overall number of participants analyzed is inconsistent with the total number of participants enrolled in each condition because these results are reflective of the 6 month assessment point. These numbers reflect the number of participants who completed this measure at the 6 month assessment.

ArmMeasureValue (MEAN)Dispersion
AboutFaceEndorsed and Anticipated Stigma Inventory (EASI)99.33 score on a scaleStandard Deviation 30.97
Enhanced Usual Care (eUC)Endorsed and Anticipated Stigma Inventory (EASI)98.76 score on a scaleStandard Deviation 30.45
Secondary

Patient Health Questionnaire (PHQ-8)

The PHQ-8 is a brief questionnaire that scores each of the 8 Diagnostic Statistical Manual (DSM)-IV criteria for depression as 0 (not at all) to 3 (nearly every day) with higher total scores indicating greater symptoms. Scores range from 0-24. PHQ-8 scores of 5, 10, 15, and 20 represent mild, moderate, moderately severe, and severe depression respectively.

Time frame: 6 months

Population: The overall number of participants analyzed is inconsistent with the total number of participants enrolled in each condition because these results are reflective of the 6 month assessment point. These numbers reflect the number of participants who completed this measure at the 6 month assessment.

ArmMeasureValue (MEAN)Dispersion
AboutFacePatient Health Questionnaire (PHQ-8)15.3 score on a scaleStandard Deviation 5.7
Enhanced Usual Care (eUC)Patient Health Questionnaire (PHQ-8)14.5 score on a scaleStandard Deviation 6.3
Secondary

Posttraumatic Stress Disorder Checklist-5 (PCL-5)

The PCL is a 20-item self-report measure of PTSD severity. The self-report rating scale is 0-4 for each symptom: Not at all, A little bit, Moderately, Quite a bit, and Extremely. Total score can range from 0-80.

Time frame: 6 months

Population: The overall number of participants analyzed is inconsistent with the total number of participants enrolled in each condition because these results are reflective of the 6 month assessment point. These numbers reflect the number of participants who completed this measure at the 6 month assessment.

ArmMeasureValue (MEAN)Dispersion
AboutFacePosttraumatic Stress Disorder Checklist-5 (PCL-5)49.9 score on a scaleStandard Deviation 16.5
Enhanced Usual Care (eUC)Posttraumatic Stress Disorder Checklist-5 (PCL-5)46.9 score on a scaleStandard Deviation 19.7
Secondary

Quality of Life Index (QLI)

The QLI is a 2-part, 33-item self-report measure of life satisfaction and importance regarding various aspects of life with higher scores representing better outcomes. Scores range from 0-30. An increase in score would represent an increase in life satisfaction.

Time frame: 6 months

Population: The overall number of participants analyzed is inconsistent with the total number of participants enrolled in each condition because these results are reflective of the 6 month assessment point. These numbers reflect the number of participants who completed this measure at the 6 month assessment.

ArmMeasureValue (MEAN)Dispersion
AboutFaceQuality of Life Index (QLI)15.5 score on a scaleStandard Deviation 2.6
Enhanced Usual Care (eUC)Quality of Life Index (QLI)15.5 score on a scaleStandard Deviation 2.5

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026